Anti-Oxidant and Pro-Oxidant Effects of Peroxiredoxin 6: A Potential Target in Respiratory Diseases

被引:16
作者
Jia, Wenhui [1 ]
Dong, Chunling [1 ]
Li, Bo [1 ,2 ]
机构
[1] Jilin Univ, Hosp 2, Dept Pulm & Crit Care Med, Changchun 130041, Peoples R China
[2] Jilin Univ, Hosp Stomatol, Dept Oral Anat & Physiol, Jilin Prov Key Lab Oral Biomed Engn, Changchun 130021, Peoples R China
关键词
oxidative stress; peroxiredoxin; 6; acute lung injury; lung cancer; anti-oxidant; reactive oxygen species; PHOSPHOLIPASE A(2) ACTIVITY; PEROXIDIZED CELL-MEMBRANES; BLOOD MONONUCLEAR-CELLS; LUNG INJURY; 1-CYS PEROXIREDOXIN; OXIDATIVE STRESS; NOX2; ACTIVATION; PRDX6; INHIBITION; IDENTIFICATION;
D O I
10.3390/cells12010181
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Peroxiredoxin 6 (PRDX6) is widely distributed in several organs, especially the lungs. The role of PRDX6 in oxidative stress is controversial and even contradictory, as indicated by research conducted over the past 20 years. PRDX6 has anti-oxidant or pro-oxidant effects on oxidative stress in different diseases. It can even exhibit both anti-oxidant and pro-oxidant effects in the same disease. These findings are attributed to the fact that PRDX6 is a multifunctional enzyme. The peroxidase and phospholipase A2 activity of PRDX6 is closely related to its anti-oxidant and pro-oxidant effects, which leads to the conflicting regulatory effects of PRDX6 on oxidative stress in respiratory diseases. Moreover, PRDX6 interacts with multiple redox signaling pathways to interfere with cell proliferation and apoptosis. PRDX6 has become a new target in respiratory disease research due to its important regulatory role in oxidative stress. In this paper, the role of PRDX6 in oxidative stress in respiratory diseases and the research progress in targeting PRDX6 are reviewed.
引用
收藏
页数:14
相关论文
共 97 条
[61]   GPx4, Lipid Peroxidation, and Cell Death: Discoveries, Rediscoveries, and Open Issues [J].
Maiorino, Matilde ;
Conrad, Marcus ;
Ursini, Fulvio .
ANTIOXIDANTS & REDOX SIGNALING, 2018, 29 (01) :61-74
[62]   Peroxiredoxin VI oxidation in cerebrospinal fluid correlates with traumatic brain injury outcome [J].
Manevich, Y. ;
Hutchens, S. ;
Halushka, P. V. ;
Tew, K. D. ;
Townsend, D. M. ;
Jauch, E. C. ;
Borg, K. .
FREE RADICAL BIOLOGY AND MEDICINE, 2014, 72 :210-221
[63]   Structure and phospholipase function of peroxiredoxin 6: identification of the catalytic triad and its role in phospholipid substrate binding [J].
Manevich, Yefim ;
Reddy, Konda S. ;
Shuvaeva, Tea ;
Feinstein, Sheldon I. ;
Fisher, Aron B. .
JOURNAL OF LIPID RESEARCH, 2007, 48 (10) :2306-2318
[64]   Binding of peroxiredoxin 6 to substrate determines differential phospholipid hydroperoxide peroxidase and phospholipase A2 activities [J].
Manevich, Yefim ;
Shuvaeva, Tea ;
Dodia, Chandra ;
Kazi, Altaf ;
Feinstein, Sheldon I. ;
Fisher, Aron B. .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2009, 485 (02) :139-149
[65]   Peroxiredoxin-6 Negatively Regulates Bactericidal Activity and NF-κB Activity by Interrupting TRAF6-ECSIT Complex [J].
Min, Yoon ;
Wi, Sae M. ;
Shin, Dongwoo ;
Chun, Eunyoung ;
Lee, Ki-Young .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2017, 7
[66]   Cancer stem cells (CSCs) in cancer progression and therapy [J].
Najafi, Masoud ;
Farhood, Bagher ;
Mortezaee, Keywan .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) :8381-8395
[67]   Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy [J].
Nie, Yan ;
Huang, Hongyan ;
Guo, Mingyan ;
Chen, Jiewen ;
Wu, Wei ;
Li, Wende ;
Xu, Xiaoding ;
Lin, Xiaorong ;
Fu, Wenkui ;
Yao, Yandan ;
Zheng, Fang ;
Luo, Man-Li ;
Saw, Phei Er ;
Yao, Herui ;
Song, Erwei ;
Hu, Hai .
CLINICAL CANCER RESEARCH, 2019, 25 (13) :3873-3886
[68]   Pulmonary surfactant metabolism in the alveolar airspace: Biogenesis, extracellular conversions, recycling [J].
Olmeda, Barbara ;
Martinez-Calle, Marta ;
Perez-Gil, Jesus .
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER, 2017, 209 :78-92
[69]   Peroxiredoxin 6 Overexpression Attenuates Cisplatin-Induced Apoptosis in Human Ovarian Cancer Cells [J].
Pak, Jhang Ho ;
Choi, Won Ho ;
Lee, Hye Mi ;
Joo, Won-Duk ;
Kim, Jong-Hyeok ;
Kim, Young-Tak ;
Kim, Yong-Man ;
Nam, Joo-Hyun .
CANCER INVESTIGATION, 2011, 29 (01) :21-28
[70]   Presenilin Mutation Suppresses Lung Tumorigenesis via Inhibition of Peroxiredoxin 6 Activity and Expression [J].
Park, Mi Hee ;
Yun, Hyung-Mun ;
Hwang, Chul Ju ;
Park, Sang Ick ;
Han, Sang Bae ;
Hwang, Dae Youn ;
Yoon, Do-Young ;
Kim, Sanghyeon ;
Hong, Jin Tae .
THERANOSTICS, 2017, 7 (15) :3624-3637